Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Forum of Clinical Oncology
Volume 8 (2017): Issue 1 (June 2017)
Open Access
Targeting Bruton Tyrosine Kinase: A novel strategy in the treatment of B-cell lymphomas
R. Sklavenitis-Pistofidis
R. Sklavenitis-Pistofidis
,
T. Koletsa
T. Koletsa
,
A. Lazaridou
A. Lazaridou
and
A. Goulas
A. Goulas
| Jun 30, 2017
Forum of Clinical Oncology
Volume 8 (2017): Issue 1 (June 2017)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Jun 30, 2017
Page range:
7 - 14
Received:
Sep 08, 2016
Accepted:
Aug 24, 2017
DOI:
https://doi.org/10.1515/fco-2015-0026
Keywords
Bruton
,
tyrosine
,
kinase
,
inhibitor
,
ibrutinib
,
BCR
,
lymphoma
,
CLL
,
treatment
© 2017 Sklavenitis-Pistofidis R., Koletsa T., Lazaridou A., Goulas A.
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.